U.S. In-Vitro Diagnostics Market is predicted to reach USD 32 Billion by 2030

U.S. In-Vitro Diagnostics Market is predicted to reach USD 32 Billion by 2030According to the study by Next Move Strategy Consulting, the U. S. In Vitro Diagnostics Market size is predicted to reach USD 32 billion, at a CAGR of 2. 9% by 2030. Request a FREE Sample: https: www. nextmsc. com us in vitro diagnostics market request sample The prevalence of chronic diseases serves as a significant growth driver for the in vitro diagnostics market in the U. S. The presence of prominent companies including Bio Rad Laboratories Inc,

According to the study by Next Move Strategy Consulting, the U.S. In-Vitro Diagnostics Market size is predicted to reach USD 32 billion, at a CAGR of 2.9% by 2030.

Request a FREE Sample: https://www.nextmsc.com/us-in-vitro-diagnostics-market/request-sample

The prevalence of chronic diseases serves as a significant growth driver for the in-vitro diagnostics market in the U.S.

The presence of prominent companies including Bio-Rad Laboratories Inc, Becton, Dickinson and Company, Abbott Laboratories, Quest Diagnostics, and others are involved in innovation, R&D activities, and collaborations which in turn foster the U.S. in-vitro diagnostics market growth.

The promising players operating in the U.S. in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.